Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | 17-AAG | 0.01 | uM | 9 | 2500.00 | 1861.36 | 2968.00 | 3928.50 | 0.7555 | 0.5418 |
| SK-BR-3 | Lapatinib | 0.031623 | uM | 9 | 2500.00 | 1861.36 | 2385.00 | 3928.50 | 0.6071 | 0.2586 |
| SK-BR-3 | Lapatinib | 0.0033113 | uM | 9 | 2500.00 | 1861.36 | 3770.00 | 3928.50 | 0.9597 | 0.9250 |
| SK-BR-3 | 17-AAG | 0.1 | uM | 9 | 2500.00 | 1861.36 | 1821.00 | 3928.50 | 0.4635 | -0.0201 |
| SK-BR-3 | Linsitinib | 0.0033113 | uM | 9 | 2500.00 | 1861.36 | 3956.00 | 3928.50 | 1.0070 | 1.0130 |
| SK-BR-3 | Linsitinib | 3.1623 | uM | 9 | 2500.00 | 1861.36 | 3186.00 | 3928.50 | 0.8110 | 0.6467 |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 9 | 2500.00 | 1861.36 | 4090.00 | 3928.50 | 1.0411 | 1.0762 |
| SK-BR-3 | Lapatinib | 1 | uM | 9 | 2500.00 | 1861.36 | 1781.00 | 3928.50 | 0.4534 | -0.0401 |
| SK-BR-3 | 0 | uM | 9 | 2500.00 | 1861.36 | 3928.00 | 3928.50 | 0.9999 | 0.9998 | |
| SK-BR-3 | 0 | uM | 9 | 5000.00 | 3570.27 | 5923.00 | 5872.75 | 1.0086 | 1.0239 | |
| SK-BR-3 | Linsitinib | 0.1 | uM | 9 | 5000.00 | 3570.27 | 5976.00 | 5872.75 | 1.0176 | 1.0491 |
| SK-BR-3 | Lapatinib | 3.1623 | uM | 9 | 5000.00 | 3570.27 | 3010.00 | 5872.75 | 0.5125 | -0.2116 |
| SK-BR-3 | Linsitinib | 10 | uM | 9 | 5000.00 | 3570.27 | 4678.00 | 5872.75 | 0.7966 | 0.4570 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 9 | 5000.00 | 3570.27 | 5773.00 | 5872.75 | 0.9830 | 0.9529 |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 9 | 5000.00 | 3570.27 | 3154.00 | 5872.75 | 0.5371 | -0.1586 |
| SK-BR-3 | Erlotinib | 1 | uM | 9 | 5000.00 | 3570.27 | 5939.00 | 5872.75 | 1.0113 | 1.0315 |
| SK-BR-3 | 17-AAG | 0.0031623 | uM | 9 | 5000.00 | 3570.27 | 5853.00 | 5872.75 | 0.9966 | 0.9906 |
| SK-BR-3 | 0 | uM | 9 | 5000.00 | 3570.27 | 5965.00 | 5872.75 | 1.0157 | 1.0439 | |
| SK-BR-3 | Linsitinib | 1 | uM | 9 | 5000.00 | 3570.27 | 5491.00 | 5872.75 | 0.9350 | 0.8213 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 9 | 5000.00 | 3570.27 | 6019.00 | 5872.75 | 1.0249 | 1.0697 |
| SK-BR-3 | Lapatinib | 0.31623 | uM | 9 | 5000.00 | 3570.27 | 2976.00 | 5872.75 | 0.5068 | -0.2240 |
| SK-BR-3 | 17-AAG | 0.0001 | uM | 9 | 5000.00 | 3570.27 | 5987.00 | 5872.75 | 1.0195 | 1.0544 |
| SK-BR-3 | 0 | uM | 9 | 5000.00 | 3570.27 | 5816.00 | 5872.75 | 0.9903 | 0.9731 | |
| SK-BR-3 | 17-AAG | 0.000302 | uM | 9 | 5000.00 | 3570.27 | 5834.00 | 5872.75 | 0.9934 | 0.9816 |
| SK-BR-3 | Erlotinib | 10 | uM | 9 | 5000.00 | 3570.27 | 3678.00 | 5872.75 | 0.6263 | 0.0423 |